Today, we’re officially launching @HalePrevention with a film called “Grow Old With Them”. You won’t see us founders in it. We wanted you to meet one of our customers, and hear his story in his own words. It captures why we built Hale better than any founder introduction could.

Heart disease is the #1 killer worldwide. With the right tools it is mostly preventable. Yet, it seems so complicated Absolutely love what Patrick and team have built at @HalePrevention

So excited to see Patrick and Palle unveil @HalePrevention to the world!

When I was just a little kid, my grandfather had a heart attack. He survived, but he was never quite the same, and no one had seen it coming. After meeting the @HalePrevention team, I learned how often that's the case, and how much of it can be caught early. It's been a privilege to advise them and pitch in on some of the design work 💙

A recent study has demonstrated that continuous exposure to rose essential oil through inhalation can lead to measurable increases in gray matter volume in the human brain. In this randomized controlled intervention, 50 healthy women participated: 28 in the experimental group applied rose essential oil to their clothing daily for one month, while 22 in the control group used plain water. Before and after the period, researchers used magnetic resonance imaging (MRI) to assess changes in brain structure. The results indicated a significant increase in gray matter volume (GMV) across the whole brain, with a particularly notable effect in the posterior cingulate cortex (PCC), a region involved in memory processing, self-referential thinking, and emotional regulation. No significant changes occurred in areas like the amygdala or orbitofrontal cortex. The olfactory pathway likely explains this effect: aromatic compounds from the rose oil travel directly to the limbic system, providing sustained stimulation that may promote neuroplasticity and help counteract age-related brain atrophy. The authors suggest this could have implications for dementia prevention, as the PCC is among the regions affected early in conditions like Alzheimer's disease. This appears to be the first evidence that prolonged scent inhalation can induce structural changes in the adult human brain. [Kokubun, K., et al. (2024). Continuous inhalation of essential oil increases gray matter volume. Brain Research Bulletin, 208, 110896. DOI: 10.1016/j.brainresbull.2024.110896]

Introducing Omanta (YC S26) the personalized research lab for each patient. Omanta integrates a patient's full medical record, personal genomics, and the latest scientific evidence to understand the molecular drivers of their disease. It maps existing and emerging therapies against their biology. And when the right treatment doesn't exist yet, it launches a personalized campaign to build it. Even the hardest cases rarely have a team dedicated to solving them. Physicians make high-stakes calls with limited time, while data and therapies emerge every week. Science moves fast, but reaching the patient can take years. That's the gap Omanta was built to close. Founders Alfredo Gonzalez, PhD and Ranad Humeidi, PhD spent years on some of the most difficult cancer cases. Alfredo led the personalized therapeutic campaign behind Sid Sijbrandij's complete remission. Together they've worked with leading institutions on personalized vaccines, CAR-T, drug repurposing, expanded access, and continuous molecular monitoring. They've seen what becomes possible when the full force of modern science is organized around one person. They met eight years ago doing early CRISPR cancer research at the Broad Institute of MIT and Harvard. Alfredo Gonzalez (CEO) has a PhD in bioinformatics from UCLA and led research projects across the Broad Institute, UCLA, and Harvard. Ranad Humeidi (CSO) has a PhD in chemical biology from Harvard, and has built and run rare-cancer programs for individual patients when standard options ran out. omanta.com A research lab, for one. Linked-in: bit.ly/omanta-linkedin YC Launch: bit.ly/omanta-yc